Myristoylated alanine-rich C kinase substrate (MARCKS)

a multirole signaling protein in cancers

Lon Wolf R. Fong, David C. Yang, Ching-Hsien Chen

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Emerging evidence implicates myristoylated alanine-rich C-kinase substrate (MARCKS), a major substrate of protein kinase C (PKC), in a critical role for cancer development and progression. MARCKS is tethered to the plasma membrane but can shuttle between the cytosol and plasma membrane via the myristoyl-electrostatic switch. Phosphorylation of MARCKS by PKC leads to its translocation from the plasma membrane to the cytosol where it functions in actin cytoskeletal remodeling, Ca2+ signaling through binding to calmodulin, and regulation of exocytic vesicle release in secretory cells such as neurons and airway goblet cells. Although the contribution of MARCKS to various cellular processes has been extensively studied, its roles in neoplastic disease have been conflicting. This review highlights the molecular and functional differences of MARCKS that exist between normal and tumor cells. We also discuss the recent advances in the potential roles of MARCKS in tumorigenesis, metastasis, and resistance to anti-cancer therapies, with a focus on addressing the inconsistent results regarding the function of MARCKS as a promoter or inhibitor of oncogenesis.

Original languageEnglish (US)
Pages (from-to)737-747
Number of pages11
JournalCancer and Metastasis Reviews
Volume36
Issue number4
DOIs
StatePublished - Dec 1 2017

Fingerprint

Neoplasms
Proteins
Cell Membrane
Cytosol
Protein Kinase C
Carcinogenesis
Goblet Cells
Calmodulin
myristoylated alanine-rich C kinase substrate
Static Electricity
Actins
Phosphorylation
Neoplasm Metastasis
Neurons
Therapeutics

Keywords

  • Drug resistance
  • MARCKS
  • Metastasis
  • Neoplastic growth
  • PI3K/AKT signaling

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Myristoylated alanine-rich C kinase substrate (MARCKS) : a multirole signaling protein in cancers. / Fong, Lon Wolf R.; Yang, David C.; Chen, Ching-Hsien.

In: Cancer and Metastasis Reviews, Vol. 36, No. 4, 01.12.2017, p. 737-747.

Research output: Contribution to journalReview article

@article{aee1c61a5dfe484681ace36503674ed1,
title = "Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers",
abstract = "Emerging evidence implicates myristoylated alanine-rich C-kinase substrate (MARCKS), a major substrate of protein kinase C (PKC), in a critical role for cancer development and progression. MARCKS is tethered to the plasma membrane but can shuttle between the cytosol and plasma membrane via the myristoyl-electrostatic switch. Phosphorylation of MARCKS by PKC leads to its translocation from the plasma membrane to the cytosol where it functions in actin cytoskeletal remodeling, Ca2+ signaling through binding to calmodulin, and regulation of exocytic vesicle release in secretory cells such as neurons and airway goblet cells. Although the contribution of MARCKS to various cellular processes has been extensively studied, its roles in neoplastic disease have been conflicting. This review highlights the molecular and functional differences of MARCKS that exist between normal and tumor cells. We also discuss the recent advances in the potential roles of MARCKS in tumorigenesis, metastasis, and resistance to anti-cancer therapies, with a focus on addressing the inconsistent results regarding the function of MARCKS as a promoter or inhibitor of oncogenesis.",
keywords = "Drug resistance, MARCKS, Metastasis, Neoplastic growth, PI3K/AKT signaling",
author = "Fong, {Lon Wolf R.} and Yang, {David C.} and Ching-Hsien Chen",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s10555-017-9709-6",
language = "English (US)",
volume = "36",
pages = "737--747",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Myristoylated alanine-rich C kinase substrate (MARCKS)

T2 - a multirole signaling protein in cancers

AU - Fong, Lon Wolf R.

AU - Yang, David C.

AU - Chen, Ching-Hsien

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Emerging evidence implicates myristoylated alanine-rich C-kinase substrate (MARCKS), a major substrate of protein kinase C (PKC), in a critical role for cancer development and progression. MARCKS is tethered to the plasma membrane but can shuttle between the cytosol and plasma membrane via the myristoyl-electrostatic switch. Phosphorylation of MARCKS by PKC leads to its translocation from the plasma membrane to the cytosol where it functions in actin cytoskeletal remodeling, Ca2+ signaling through binding to calmodulin, and regulation of exocytic vesicle release in secretory cells such as neurons and airway goblet cells. Although the contribution of MARCKS to various cellular processes has been extensively studied, its roles in neoplastic disease have been conflicting. This review highlights the molecular and functional differences of MARCKS that exist between normal and tumor cells. We also discuss the recent advances in the potential roles of MARCKS in tumorigenesis, metastasis, and resistance to anti-cancer therapies, with a focus on addressing the inconsistent results regarding the function of MARCKS as a promoter or inhibitor of oncogenesis.

AB - Emerging evidence implicates myristoylated alanine-rich C-kinase substrate (MARCKS), a major substrate of protein kinase C (PKC), in a critical role for cancer development and progression. MARCKS is tethered to the plasma membrane but can shuttle between the cytosol and plasma membrane via the myristoyl-electrostatic switch. Phosphorylation of MARCKS by PKC leads to its translocation from the plasma membrane to the cytosol where it functions in actin cytoskeletal remodeling, Ca2+ signaling through binding to calmodulin, and regulation of exocytic vesicle release in secretory cells such as neurons and airway goblet cells. Although the contribution of MARCKS to various cellular processes has been extensively studied, its roles in neoplastic disease have been conflicting. This review highlights the molecular and functional differences of MARCKS that exist between normal and tumor cells. We also discuss the recent advances in the potential roles of MARCKS in tumorigenesis, metastasis, and resistance to anti-cancer therapies, with a focus on addressing the inconsistent results regarding the function of MARCKS as a promoter or inhibitor of oncogenesis.

KW - Drug resistance

KW - MARCKS

KW - Metastasis

KW - Neoplastic growth

KW - PI3K/AKT signaling

UR - http://www.scopus.com/inward/record.url?scp=85031895146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031895146&partnerID=8YFLogxK

U2 - 10.1007/s10555-017-9709-6

DO - 10.1007/s10555-017-9709-6

M3 - Review article

VL - 36

SP - 737

EP - 747

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 4

ER -